A candidate antineoplastic herbal agent for bladder cancer: Ankaferd Blood Stopper

Hilmi Sarı1, Serdar Çelik2,3, Fulya Çağlar2

  • 1Department of Urology, School of Medicine, Dokuz Eylul University, Izmir, Turkey.

Abstract

Insights

Ankaferd Blood Stopper (ABS) demonstrated cytotoxic effects on bladder cancer cells in vitro, reducing viability and inducing necroptosis. Further research into ABS as an intravesical treatment for bladder cancer is warranted.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Ankaferd Blood Stopper (ABS) has shown antineoplastic effects on osteosarcoma and colon carcinoma cell lines.
  • Investigating novel therapeutic agents for bladder cancer is crucial due to its prevalence.

Purpose of the Study:

  • To evaluate the antineoplastic effect of Ankaferd Blood Stopper (ABS) on human bladder cancer cell cultures.
  • To determine the impact of ABS on cancer cell viability, apoptosis, and necroptosis.

Main Methods:

  • Primary bladder cancer cell cultures were established from fresh frozen tumor samples.
  • Cancer cell cultures were treated with two different doses of ABS.
  • Cell viability, apoptosis, and necroptosis were assessed using viability tests and flow cytometry.

Main Results:

  • A decreased cancer cell viability ratio was observed in ABS-treated groups compared to controls.
  • Necroptosis was the predominant cell death mechanism observed in most ABS-treated cultures.
  • Apoptosis was also detected in some bladder cancer cell cultures upon ABS treatment.

Conclusions:

  • Ankaferd Blood Stopper (ABS) exhibits a cytotoxic effect on bladder cancer cells in vitro.
  • The findings suggest potential for ABS as an intravesical therapeutic agent for bladder cancer.
  • Further studies, including animal models, are recommended to explore ABS's efficacy and safety for intravesical application.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
303
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
392
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K